Neurotoxicity of Spermine Synthase-deficiency and Polyamine Imbalance

精胺合酶缺乏和多胺失衡的神经毒性

基本信息

  • 批准号:
    10242802
  • 负责人:
  • 金额:
    $ 32.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-30 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Neurotoxicity of Spermine Synthase-Deficiency and Polyamine Imbalance PROJECT SUMMARY Polyamines, namely spermidine, spermine, and their precursor putrescine are tightly regulated polycations essential for life. Dysregulation of polyamine metabolism has been observed to accompany several neurological disease conditions include hypoxic and ischemic brain damage. However, the pathological consequence of polyamine imbalance in the nervous system remains unclear. The pivotal role of polyamine metabolism in the nervous system recently emerged with the mapping of causal mutation of Snyder-Robinson Intellectual Disability Syndrome (SRS, OMIM 309583) to spermine synthase (SMS), an enzyme that catalyzes the conversion of spermidine to spermine. SRS is the first confirmed genetic disorder associated with the polyamine metabolic pathway. Neurological manifestations in SRS indicate the long-term pathological consequence of polyamine imbalance, and provide a unique opportunity to uncover nervous system-specific function of SMS and polyamine metabolism. We have established a Drosophila model for SRS and found that human and Drosophila SMS proteins are functionally conserved, and loss of SMS in Drosophila recapitulated several key features of SRS pathology, including polyamine imbalance, reduced survival rate, and synaptic dysfunction. We discovered that SMS deficiency leads to excessive spermidine catabolism, and consequent lysosomal dysfunction and oxidative stress in vivo. We hypothesize that spermidine/spermine imbalance due to SMS deficiency causes altered polyamine catabolism, and that neutralizing the detrimental metabolites from polyamine catabolism will ameliorate phenotypes and disease progression in SRS. In this application, we will characterize the neuronal function of SMS in vivo, analyze the neurotoxicity resulted from polyamine imbalance, study cellular phenotypes in SRS patient blood lymphoblast, skin fibroblast and bone BMSC cells, and further discover genetic suppressors and potential pharmacological interventions for SRS. The proposed work will provide significant and important insights into the function of polyamines and SMS, and delineate the neuronal mechanisms underlying the neuropathology of spermine synthase-deficiency, and have long-lasting and sustained impact on polyamine-associated neurological disorders.
精胺合酶缺乏和多胺失衡的神经毒性 项目摘要 多胺,即亚精胺,精胺,和它们的前体腐胺是严格管制的 生命所必需的聚阳离子。已经观察到多胺代谢的失调伴随着几种 神经疾病病症包括缺氧和缺血性脑损伤。然而,病理 神经系统中多胺失衡的后果尚不清楚。多胺的关键作用 神经系统中的代谢最近出现了Snyder-Robinson因果突变的映射 智力障碍综合征(SRS,OMIM 309583)与精胺合酶(SMS),一种催化 亚精胺向精胺的转化。SRS是第一个被证实的遗传性疾病, 多胺代谢途径SRS的神经系统表现提示SRS的长期病理改变 多胺失衡的后果,并提供了一个独特的机会,揭示神经系统特异性 SMS和多胺代谢的功能。我们建立了一个果蝇SRS模型,发现 人类和果蝇的SMS蛋白在功能上是保守的,果蝇中SMS的丢失也是重演 SRS病理学的几个关键特征,包括多胺失衡、存活率降低和突触 功能障碍我们发现,SMS缺乏导致过量的亚精胺催化剂, 溶酶体功能障碍和体内氧化应激。我们假设亚精胺/精胺失衡是由于 SMS缺乏导致改变的多胺催化剂,中和有害的代谢物, 多胺催化剂将改善SRS的表型和疾病进展。在这个应用程序中,我们将 在体内研究SMS的神经功能,分析多胺的神经毒性 研究SRS患者血液淋巴母细胞、皮肤成纤维细胞和骨BMSC细胞中细胞表型, 并进一步发现SRS的遗传抑制因子和潜在的药物干预。拟议 这项工作将为多胺和SMS的功能提供重要而重要的见解,并描绘出 精胺脱氢酶缺乏的神经病理学基础的神经机制,并具有长期的 和对多胺相关神经系统疾病的持续影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rong Grace Zhai其他文献

Rong Grace Zhai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rong Grace Zhai', 18)}}的其他基金

Neurotoxicity of Spermine Synthase-deficiency and Polyamine Imbalance
精胺合酶缺乏和多胺失衡的神经毒性
  • 批准号:
    10752966
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
microRNA regulation of NMNAT-mediated Neuroprotection against Peripheral Neuropathy and Chronic Pain
NMNAT 介导的针对周围神经病变和慢性疼痛的神经保护的 microRNA 调节
  • 批准号:
    10704161
  • 财政年份:
    2019
  • 资助金额:
    $ 32.16万
  • 项目类别:
microRNA regulation of NMNAT-mediated Neuroprotection against Peripheral Neuropathy and Chronic Pain
NMNAT 介导的针对周围神经病变和慢性疼痛的神经保护的 microRNA 调节
  • 批准号:
    10677059
  • 财政年份:
    2019
  • 资助金额:
    $ 32.16万
  • 项目类别:
microRNA regulation of NMNAT-mediated Neuroprotection against Peripheral Neuropathy and Chronic Pain
NMNAT 介导的针对周围神经病变和慢性疼痛的神经保护的 microRNA 调节
  • 批准号:
    10879437
  • 财政年份:
    2019
  • 资助金额:
    $ 32.16万
  • 项目类别:
Neurotoxicity of Spermine Synthase-deficiency and Polyamine Imbalance
精胺合酶缺乏和多胺失衡的神经毒性
  • 批准号:
    10445331
  • 财政年份:
    2018
  • 资助金额:
    $ 32.16万
  • 项目类别:
Neurotoxicity of Spermine Synthase-deficiency and Polyamine Imbalance
精胺合酶缺乏和多胺失衡的神经毒性
  • 批准号:
    10015358
  • 财政年份:
    2018
  • 资助金额:
    $ 32.16万
  • 项目类别:
Mechanisms of Neuronal Maintenance and Protection.
神经元维持和保护机制。
  • 批准号:
    8489360
  • 财政年份:
    2009
  • 资助金额:
    $ 32.16万
  • 项目类别:
Mechanisms of Neuronal Maintenance and Protection.
神经元维持和保护机制。
  • 批准号:
    7737404
  • 财政年份:
    2009
  • 资助金额:
    $ 32.16万
  • 项目类别:
Mechanisms of Neuronal Maintenance and Protection.
神经元维持和保护机制。
  • 批准号:
    8269077
  • 财政年份:
    2009
  • 资助金额:
    $ 32.16万
  • 项目类别:
Mechanisms of Neuronal Maintenance and Protection.
神经元维持和保护机制。
  • 批准号:
    8097985
  • 财政年份:
    2009
  • 资助金额:
    $ 32.16万
  • 项目类别:

相似海外基金

Replacing Aldehydes in Reductive Amination
在还原胺化中取代醛
  • 批准号:
    2870985
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Studentship
Free vs bound Strecker aldehydes Impact on chocolate aroma perception
游离与结合的 Strecker 醛对巧克力香气感知的影响
  • 批准号:
    BB/Y512436/1
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Training Grant
Reactive aldehydes and alcohol misuse in lung infections
肺部感染中的活性醛和酒精滥用
  • 批准号:
    10581148
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
Free vs. bound Strecker aldehydes - Impact on chocolate aroma perception
游离与结合的 Strecker 醛 - 对巧克力香气感知的影响
  • 批准号:
    2884978
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Studentship
Advancing the Curation of Aldehydes and Ketones for Applications to Cometary Material
推进醛类和酮类在彗星材料中的应用
  • 批准号:
    563498-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 32.16万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigation of the usefulness of aldehydes in exhaled breath gas as prostate cancer biomarkers
研究呼出气体中的醛作为前列腺癌生物标志物的有用性
  • 批准号:
    21K18089
  • 财政年份:
    2021
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Aziridine Aldehydes: Novel Reaction Discovery through Amphoterism
氮丙啶醛:通过两性发现新反应
  • 批准号:
    534459-2019
  • 财政年份:
    2021
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Highly active iron precatalyst for hydrosilylation of ketones and aldehydes using industrially viable silanes - Phase I
使用工业上可行的硅烷进行酮和醛氢化硅烷化的高活性铁预催化剂 - 第一阶段
  • 批准号:
    566839-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Idea to Innovation
SELF-MASKED ALDEHYDES AS INHIBITORS OF THE CYSTEINE PROTEASES 3CL PROTEASE, CATHEPSIN L, AND CRUZAIN
自掩蔽醛作为半胱氨酸蛋白酶 3CL 蛋白酶、组织蛋白酶 L 和 CruzAIN 的抑制剂
  • 批准号:
    10355007
  • 财政年份:
    2021
  • 资助金额:
    $ 32.16万
  • 项目类别:
Understanding the molecular pathways that underpin production, sensing and protection against aldehydes
了解支持醛类产生、传感和防护的分子途径
  • 批准号:
    2595805
  • 财政年份:
    2021
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了